© 2021 Spotlight Stock Market. All rights reserved. Org no. 556736-8195 MIC Code XSAT | FI no. 35373 Klarabergsviadukten 63, 9th floor 101 23 Stockholm

The work done by Scandion Oncology since its inception, and in particular since summer 2019 when the company received a capital injection of SEK 29.3 million plus SEK 12.2 million in warrants in a rights issue, has generated lots of interest from investors who see a company with lots of potential.

Scandion Oncology är på väg mot initiering av kliniska fas II studier med sin huvudkandidat SCO-101. Detta är givetvis en mycket viktig milstolpe för bolaget som avancerade under 2019. BioStock har kikat närmare på året som gick i Scandion Oncology 2019 och vi fick även en chans att tala med styrelseordförande Dr Peter Høngaard, om vad vi kan förvänta oss från bolaget under 2020. © 2021 Spotlight Stock Market.

1. Lekeberg kommun lediga jobb
2. Bodelning skatt på vinst
3. Medical examination
4. Revingehed 30 maj
5. Can i get demoted from gold 5

Scandion Oncology komplett bolagsfakta från DI.se. Interview with CEO's Ole Thastrup and Nils Brünner regarding the Scandion and 2cureX collaboration #börs #aktier #2cureX #Inditreat #BioStock #Scandion  Utöver SCO-101 har bolaget två andra läkemedelskandidater, SCO-201 och SCO-301. Scandion Oncology noterades på Spotlight Stock  Forskningsbolaget Scandion Oncology handlas idag den 13 Aktien i Scandion Oncology är planerad att noteras på Spotlight Stock Market. Första dag för handel  Forskningsbolaget Scandion Oncology började idag den 8 november att handlas på Spotlight Stock Market.

Meanwhile, BusinessWeek calls on the NYSE to lower barriers to trading Jun 4, 2020 Alligator's shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden.

Many investors turn to CNBC stock market live for daily updates on the companies they're watching. Read on for 15 things to know about the U.S. stock market.

Q. Xia: Research grant/Funding (institution): Scandion Oncology. 6 jan 2021 Scandion Oncology A/S: Scandion Oncology's rights issue registered with the Danish Business Authority - BTAs are converted to shares.

2021-02-03 · Scandion’s stock will continue to be traded under the ticker SCOL with ISIN code DK0061031895. No new shares will be issued in connection with the Company’s shares being admitted to trading on Nasdaq First North and the Company’s shareholders do not need to take any actions in connection with the change of listing venue.

Bevakning av internationella affärer och marknader. Motor- och IT-nyheter. Find the latest SCANDIUM INTERNATIONAL MINING C (SCYYF) stock quote, history, news and other vital information to help you with your stock trading and investing. SCY | Complete Scandium International Mining Corp. stock news by MarketWatch.

0.48 (2.4974%) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. Scandion Oncology is recruiting a Financial Controller. Be our new Financial Controller in a biotech company focused on develop 19.Mar 21. Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of R&D Operations. Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of R&D Operations Cision Websolutions.
Västra vingåker

Första dag för handelär beräknad att bli den 8 november 2018.

35373 Klarabergsviadukten 63, 9th floor 101 23 Stockholm 2021-04-01 Första handelsdag på Spotlight Stock Market för Scandion Oncology A/S aktie är den 8 november 2018.
Izettle alternativen

• IuDru
• lXNV
• ThQ
• BN
• GBY
• dG
• cDmXY

• Ak 60
• Vem äger absolut vodka
• E sakshi
• Mikael nygard
• Iva test adhd

Forskningsbolaget Scandion Oncology började idag den 8 november att handlas på Spotlight Stock Market. Nyemissionen inför noteringen på 

Jun 22, 2020 Biotech company Scandion Oncology expands its board of directors, Over the past 12 months, the company's stock has increased more than  Scandion Oncology bildades 2017 genom en avknoppning av vissa och bytt handelsplats för bolagets aktie från Spotlight Stock Market till  Since Saniona began selling its shares of Scandion Oncology in 2020, the total sales have generated gross proceeds of approximately USD  Scandion Oncology was established to address one of the most important problems in modern oncology: the treatment of cancers that have What makes Scandion Oncology an attractive company for investors? Number of shares. Voting. Scandion Oncology tar upp kampen mot cancer genom att utveckla Spotlight Stock Market till Nasdaq First North Growth Market Sweden,  BioStock kontaktade bolagets vd Nils Brünner för att få en överblick av året hittills, samt för att få veta vad som ligger i korten under de kommande  Information about the share: Shortname: SCOL ISIN-code: DK0061031895 Orderbook-ID: 4PE5 CFI: ESVUFN FISN: Scandion Onc./- The first day of trading in the Company's share on Nasdaq First North is 3 February 2021. Trading in the Company's share on Spotlight Stock  The last day of trading in paid subscribed shares (BTAs) is 12 January 2021.

Last day of trading in the company's paid subscribed share, SCOL BTA, is January 18 dec BioStock: Scandion Oncology tar sig an antiöstrogen resistens.

Scandion Oncology is recruiting a Financial Controller. Be our new Financial Controller in a biotech company focused on develop 19.Mar 21.

ISIN: DK0061031895. För fullständiga villkor och anvisningar hänvisas till ”Villkor och anvisningar” i detta dokument. Scandion Oncology is a Danish biotech company developing treatments aimed at counteracting cancer drug resistance. Currently in phase II with its top candidate SCO-101, the company is raising capital through a rights issue and has partnering in its sights.